RECOMBINATE 1000 IU

Krajina: Izrael

Jazyk: angličtina

Zdroj: Ministry of Health

Aktívna zložka:

COAGULATION FACTOR VIII RECOMBINANT 1000 IU/VIAL

Dostupné z:

TEVA MEDICAL MARKETING LTD.

ATC kód:

B02BD02

Forma lieku:

POWDER FOR SOLUTION FOR INJECTION

Spôsob podávania:

I.V

Výrobca:

BAXTER S.A., BELGIUM

Terapeutické skupiny:

COAGULATION FACTOR VIII

Terapeutické indikácie:

The use of Recombinate is indicated in the treatment and prophylaxis of bleeding in patients with haemophilia A (congenital factor VIII deficiency). Recombinate is also indicated in the perioperative management of patients with haemophilia A. Recombinate is appropriate for use in children of all ages including the newborn. (Safety and efficacy studies have been performed in both previously treated and previously untreated children). The product in not suitable for the treatment of von Willebrand's disease.

Dátum Autorizácia:

2010-07-01